Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
PharmaBridgeconsulting ApS
APS
Dissolved
Advertising protection
CVR 44402777
Ådalsvej 225, 5250
Odense SV
All other professional, scientific and technical activities n.e.c.
·
NACE 7499
Est. 2023 · 2 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
All other professional, scientific and technical activities n.e.c.
/
PharmaBridgeconsulting ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
1M
1M
1M
0M
0M
2024: 1M
1M
2024
EBITDA
DKK millions
0M
0M
0M
-1M
-1M
2024: 0M
0M
2024
Income statement
DKK thousands
Item
2024
Gross profit
541
Staff expenses
-135
EBITDA
406
Depreciation & amort.
-0
EBIT
406
Net financials
-2
Profit before tax
405
Tax
91
Net profit
314
Balance sheet
DKK thousands
Item
2024
Total assets
479
Equity
354
Long-term debt
0
Short-term debt
124
Total debt
124
Financial ratios
5-year trend
EBITDA margin (of gross profit)
75,1 %
This company
2024
2024
Equity ratio
74,0 %
This company
38,2 %
Market median
This company
Market median
94% above market
2024
2024
Return on equity
88,7 %
This company
18,4 %
Market median
This company
Market median
382% above market
2024
2024
Net profit margin (of gross profit)
58,0 %
This company
2024
2024
Asset turnover (of gross profit)
1,13×
This company
2024
2024
Debt / equity
0,35×
This company
0,62×
Market median
This company
Market median
44% below market
2024
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2023-11-01 – 2024-12-31
View
PDF
More on PharmaBridgeconsulting ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
